drugset / Trial / NCT06647550
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Timeline
- Start
- 2024-12-12
- Primary completion
- 2025-03-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HD-6277 | Unknown | 25 mg | Oral |
| Subject | HD-6277 | Unknown | 50 mg | Oral |
| Subject | HD-6277 | Unknown | 100 mg | Oral |